Antiproliferative and anti-tumor activity of organotin compounds

Published on Jan 1, 2009in Coordination Chemistry Reviews13.48
· DOI :10.1016/j.ccr.2007.12.026
Sotiris K. Hadjikakou34
Estimated H-index: 34
(UoI: University of Ioannina),
Nick Hadjiliadis36
Estimated H-index: 36
(UoI: University of Ioannina)
Tin compounds and their therapeutic potentials are under consideration from many research groups, while a number of early reviews recording advances in the screening for antiproliferative potential of organotins are also available. This review focuses upon results obtained on the antiproliferative activity of tin compounds in the past 5 years.
  • References (53)
  • Citations (270)
#1Marianna N. Xanthopoulou (UoI: University of Ioannina)H-Index: 9
#2Sotiris K. Hadjikakou (UoI: University of Ioannina)H-Index: 34
Last.Spyros Karkabounas (UoI: University of Ioannina)H-Index: 14
view all 10 authors...
#1Charles E. Carraher (FAU: Florida Atlantic University)H-Index: 24
#2Theodore S. Sabir (FAU: Florida Atlantic University)H-Index: 1
Last.Kelly D. Bassett (UTA: University of Texas at Arlington)H-Index: 3
view all 7 authors...
#1Muhammad S. Khan (Gomal University)H-Index: 19
#2Musa Kaleem Baloch (Gomal University)H-Index: 13
Last.G. Stoter (Erasmus University Medical Center)H-Index: 35
view all 4 authors...
Cited By270
#1Marcus Vinícius Juliaci Rocha (Federal Fluminense University)H-Index: 1
#2Felipe de S. Vilhena (Federal Fluminense University)H-Index: 2
Last.Luciano T. Costa (Federal Fluminense University)H-Index: 6
view all 6 authors...
#1Arshad Farooq Butt (Mirpur University of Science and Technology)H-Index: 1
#2Muhammad Naeem Ahmed (University of Azad Jammu and Kashmir)H-Index: 6
Last.Tariq Mahmood (CUI: COMSATS Institute of Information Technology)H-Index: 11
view all 7 authors...
#1C.N. Banti (UoI: University of Ioannina)H-Index: 16
#2Sotiris K. Hadjikakou (UoI: University of Ioannina)H-Index: 34
Last.Nick Hadjiliadis (UoI: University of Ioannina)H-Index: 36
view all 4 authors...
View next paperOrganometallic compounds in oncology: implications of novel organotins as antitumor agents.